IMA IMAGENEBIO INC revenue, earnings and financials

For the quarter ended June 30, 2026, IMAGENEBIO INC reported revenue of n/a, net income of −$10.2M and diluted EPS of −$0.63; for the fiscal year ended December 2025 revenue was $800K, down 77.1% on the year before.

IMA annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $800K, gross profit n/a, operating income −$48.5M, net income −$45.3M (margin -5668.6%), EPS −$9.64
• Fiscal year ended Dec 2024: revenue $3.50M, gross profit n/a, operating income −$37.0M, net income −$36.6M (margin -1044.8%), EPS −$22.10
• Fiscal year ended Dec 2023: revenue $9.16M, gross profit n/a, operating income −$75.4M, net income −$68.2M (margin -744.2%), EPS −$1.63
• Fiscal year ended Dec 2022: revenue $15.6M, gross profit n/a, operating income −$70.9M, net income −$68.8M (margin -440.3%), EPS −$1.90
• Fiscal year ended Dec 2021: revenue $31.0M, gross profit n/a, operating income −$34.1M, net income −$34.1M (margin -110.1%), EPS −$1.22

IMA quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue n/a, net income −$10.2M, EPS −$0.63
• Quarter ended Mar 31, 2026: revenue n/a, net income −$10.6M, EPS −$0.95
• Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$6.91M, EPS $1.53
• Quarter ended Sep 30, 2025: revenue $0 (down 100.0% year over year), net income −$24.8M, EPS −$2.91
• Quarter ended Jun 30, 2025: revenue n/a, net income −$7.59M, EPS −$4.46
• Quarter ended Mar 31, 2025: revenue $800K, net income −$6.08M, EPS −$3.80
• Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$4.81M, EPS −$18.91
• Quarter ended Sep 30, 2024: revenue $3.50M (up 195.4% year over year), net income −$3.18M, EPS −$2.58
• Quarter ended Jun 30, 2024: revenue n/a, net income −$6.26M, EPS −$0.28
• Quarter ended Mar 31, 2024: revenue n/a, net income −$22.3M, EPS −$0.33
• Quarter ended Dec 31, 2023 (from the annual report): revenue $658K (down 87.9% year over year), net income −$19.5M, EPS −$0.40
• Quarter ended Sep 30, 2023: revenue $1.19M (down 81.5% year over year), net income −$17.3M, EPS −$0.40
• Quarter ended Jun 30, 2023: revenue $2.00M (up 424.6% year over year), net income −$17.1M, EPS −$0.44
• Quarter ended Mar 31, 2023: revenue $5.31M (up 57.0% year over year), net income −$14.2M, EPS −$0.39
• Quarter ended Dec 31, 2022 (from the annual report): revenue $5.45M (down 73.0% year over year), net income −$14.1M, EPS −$0.38
• Quarter ended Sep 30, 2022: revenue $6.40M (up 70.9% year over year), net income −$17.3M, EPS −$0.48
• Quarter ended Jun 30, 2022: revenue $382K (down 89.2% year over year), net income −$20.5M, EPS −$0.57
• Quarter ended Mar 31, 2022: revenue $3.38M (down 2.6% year over year), net income −$16.8M, EPS −$0.47
• Quarter ended Dec 31, 2021 (from the annual report): revenue $20.2M, net income $2.80M, EPS $2.05
• Quarter ended Sep 30, 2021: revenue $3.75M, net income −$14.5M, EPS −$0.40

IMA cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$47.8M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$21.3M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$79.7M, share buybacks $663K
• Fiscal year ended Dec 2022: operating cash flow −$74.1M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$60.3M, share buybacks n/a

IMA balance sheet

• Jun 30, 2026: cash $94.7M, total assets $152M, total liabilities $9.97M, shareholders' equity $142M
• Mar 31, 2026: cash $76.0M, total assets $137M, total liabilities $13.4M, shareholders' equity $123M
• Dec 31, 2025: cash $94.5M, total assets $153M, total liabilities $19.8M, shareholders' equity $133M
• Sep 30, 2025: cash $103M, total assets $161M, total liabilities $21.0M, shareholders' equity $140M
• Jun 30, 2025: cash $58.3M, total assets $126M, total liabilities $10.3M, shareholders' equity −$180M
• Mar 31, 2025: cash $36.8M, total assets $131M, total liabilities $12.6M, shareholders' equity −$170M
• Dec 31, 2024: cash $12.1M, total assets $15.9M, total liabilities $17.4M, shareholders' equity −$161M
• Sep 30, 2024: cash $45.2M, total assets $149M, total liabilities $14.8M, shareholders' equity −$153M

What is IMA's revenue?

IMAGENEBIO INC reported $800K of revenue for the fiscal year ended December 2025.

Is IMA profitable?

No. IMAGENEBIO INC lost $52.5M over the last four quarters.

What is IMA's EPS?

Diluted earnings per share over the last four quarters were −$2.96; −$0.63 in the latest quarter.

IMA ownership and insider trades · All stocks